Aleglitazar, a dual peroxisome proliferator-activated receptor- and - agonist, protects cardiomyocytes against the adverse effects of hyperglycaemia

Chen, Y; Chen, HM; Birnbaum, Y; Nanhwan, MK; Bajaj, M; Ye, YM; Qian, JQ

Qian, JQ (reprint author), Kunming Med Univ, Dept Anesthesiol, Affiliated Hosp 1, 295 Xichang Rd, Kunming 650032, Peoples R China.

DIABETES & VASCULAR DISEASE RESEARCH, 2017; 14 (2): 152

Abstract

Purpose: To assess the effects of Aleglitazar on hyperglycaemia-induced apoptosis. Methods: We incubated human cardiomyocytes, cardiomyocytes from car......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索